Table 1. Patient demographics, clinical features and cell line designations.

Cell Line Designation	Location	Histologya,[15]	Primary Treatment	Treatment at Recurrence	Overall Survival (Months)
GS1	Right fronto-temporal	Gliosarcoma	Surgical resection	N/A	4.3
TS1	Left frontal & thalamic	Gliomatosis cerebri	Biopsy only	N/A	1.3
TS6	Right frontal	GBM	Surgical resection + TMZ +Irradiation	PCV	9.2
TS9	Left frontal	Recurrent GBM	Surgical resection + TMZ +Irradiation	Surgical resection +PCV	14.3
TS17	Right occipital	GBM	Surgical resection	N/A	0.9
TS18	Left parietal	GBM	Surgical resection	N/A	5.6
TS20	Left frontal	GBM	Surgical resection + TMZ +Irradiation	N/A	8.4

^aHistological diagnoses were made prior to the WHO 2016 re-classification. Gliomatosis cerebri is now referred to as a rare diffuse-pattern glioblastoma and gliosarcoma has been incorporated into the umbrella term IDH-wildtype glioblastoma.